President Donald J. Trump recently signed the Small Business Innovation and Economic Security Act (S. 3971) into law, reauthorizing the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through September 30, 2031. This legislation ends a lapse in funding that began in October 2025, restoring approximately $6 billion in federal research and development funds for small businesses. Research projects that were paused for the past six months waiting for funding to resume can now submit the applications they prepared last summer.

The legislation includes sweeping changes to the SBIR and STTR programs that every innovation-driven company needs to understand. The landscape has shifted, and the companies that adapt fastest will be best positioned to capture what remains one of the most significant federal funding mechanisms for small business research and development. Or as the government now brands it: “America’s Seed Fund.”

The Funding Freeze Is Over

On Sept. 30, 2025, congressional authorization for SBIR and STTR expired amid a floor dispute over whether to reform the programs immediately or extend them as-is for another year. The result was a complete halt: federal agencies were prohibited from issuing new solicitations or committing new funds. The consequences were immediate and far-reaching, with thousands of small businesses at critical stages of early development unable to secure funding.

A bipartisan compromise eventually emerged that was unanimously passed by the Senate on March 3, 2026, approved by the House on March 17 and signed by the President on April 13. The Small Business Innovation and Economic Security Act reauthorizes the programs through fiscal year 2031, but the compromise does far more than appropriate funding.

What Changed

A Crackdown on 'SBIR Mills'

One of the most discussed provisions targets companies that have made a business model out of winning federal grants without ever meaningfully commercializing the resulting technology. Essentially impacting only about 20 companies seeking mostly Defense Department grants, the new law requires all federal granting agencies to impose caps on the number of proposals a single small business can submit — whether on a per-fiscal-year, per-solicitation or per-topic basis.

For new entrants, this is welcome news. Fewer applications from repeat awardees means a less crowded field. But because of a handful of companies abusing the system, the legislation raises the stakes for all: with fewer bites at the apple for everyone, each proposal must be sharper, more commercially viable and more scientifically rigorous than ever before.

The Strategic Breakthrough Allocation

This is the provision that has the potential to fundamentally reshape the funding landscape. Historically, standard SBIR/STTR awards capped out between $1 million and $2 million — an amount often viewed as insufficient for capital-intensive technologies like advanced manufacturing, energy and defense.

The new Strategic Breakthrough Allocation allows agencies with more than $100 million in extramural R&D budgets to make awards of up to $30 million, either as a single grant or a series of phased awards. These larger awards are intended for critical, capital-intensive technologies that require significant investment to move from prototype to production.

The potential downside is that these mega-awards draw from the existing SBIR/STTR funding pool. That means more money flowing to fewer recipients. While companies pursuing these awards will also need to secure mandatory 1:1 matching funds from private investors, the prospect of non-dilutive SBIR matching funds will encourage such investment. Nonetheless, the practical effect is a consolidation of funding that will reward the most competitive applicants while potentially reducing the total number of awards available.

Strengthened Foreign Ownership Scrutiny

Owing to growing national security concerns, the legislation strengthens and more explicitly defines the due diligence review process for small businesses' foreign ownership and financial ties. Companies seeking SBIR/STTR funding should expect more rigorous vetting of their ownership structures, investor relationships and any connections to foreign entities.

Why This Matters

Whether you are a startup founder, a university spinning out new technology or an established small firm serving government customers, the reauthorized SBIR/STTR programs demand a recalibrated strategy.

• If you are a first-time applicant: The playing field is more level than it has been in years. With application caps limiting repeat awardees, new entrants have a genuine window of opportunity — but only if their proposals demonstrate clear paths to commercialization.
• If you are pursuing capital-intensive technology: The Strategic Breakthrough Allocation opens the door to transformative levels of federal funding. But securing a $30 million award will require robust private co-investment and an extraordinarily competitive application. Start building relationships with investors now.
• If you work with academic partners: The new rules make university partnerships more valuable than ever. Tech transfer offices can provide the scientific credibility and infrastructural support that distinguish a winning proposal from the pack. In particular, STTR applicants should be deepening their ties to research institutions.
• If you have foreign investors or ownership ties: Begin reviewing your corporate structure and investor relationships immediately. Enhanced due diligence requirements mean that unresolved questions about foreign financial ties could disqualify an otherwise strong application.
• If you are a current SBIR/STTR awardee: Existing obligations remain intact, but understand that the competitive dynamics of future solicitations have changed. The emphasis on commercialization outcomes and improved data tracking means agencies will be watching more closely to see whether their investments translate into real-world products and capabilities.

The Bigger Picture

The SBIR and STTR programs distribute nearly $6 billion annually across 11 federal agencies and have fueled more than 70,000 patents, 700 public companies and $41 billion in venture capital investment since their inception. They remain one of the most powerful tools the federal government has for converting taxpayer-funded research into commercial and national security capabilities.

SBIR and STTR grants remain attractive for several reasons. Founders do not give up shares, allowing them to keep full decision-making power and higher potential future financial gains. The existence of such non-dilutive funding is also attractive to future investors. Unlike loans, these grants do not need to be repaid, making them "free money" for research and development.

Furthermore, obtaining an SBIR or STTR grant serves as a "stamp of approval" from federal agencies, which significantly increases credibility with future investors and potential partners. The grants provide capital for early-stage feasibility and proof-of-concept projects that at the early stage are often too risky for private investors. And by funding development without reducing founder equity, companies can achieve higher valuations before seeking venture capital or angel investment. And those investors obtain a greater share of a more valuable company.

But the reauthorization also arrives at a moment of intense geopolitical competition. Supply-chain vulnerabilities, strained defense stockpiles and accelerating technology races with near-peer competitors have made the health of America's small business industrial base a matter of national urgency. Congress is proffering a reformed SBIR/STTR framework — one that rewards commercialization, limits grant dependency and channels larger sums toward breakthrough technologies — to help close the so-called "valley of death" between prototype and production.

What You Should Do Now

There is now a window for strategic positioning that didn’t exist before the legislation was passed. Companies that take the following steps will be best prepared to compete under the new rules:

• Audit your SBIR/STTR application history and assess how proposal caps may affect your strategy, especially for how your work is staged.
• Evaluate whether your technology qualifies for the Strategic Breakthrough Allocation and begin identifying co-investment partners, including state or regional economic development matching funds.
• Review your corporate ownership structure for any foreign ties that could trigger enhanced scrutiny.
• Strengthen relationships with university tech transfer offices and research partners.
• Consult with experienced patent, new venture and government contracts counsel to ensure your intellectual property and corporate strategies align with the new funding landscape.

For more information, please contact Peter J. Butch III at pbutch@foxrothschild.com, or another member of Fox Rothschild’s Intellectual Property Department.

This information is intended to inform firm clients and friends about legal developments, including the decisions of courts and administrative bodies. Nothing in this alert should be construed as legal advice or a legal opinion. Readers should not act upon the information contained in this alert without seeking the advice of legal counsel. Views expressed are those of the author(s) and not necessarily this law firm or its clients. Prior results do not guarantee a similar outcome.